Literature DB >> 35766592

Propofol versus lidocaine on prevention of laryngospasm in tonsillectomy: A randomized clinical trial.

Nahid Manouchehrian1, Nasrin Jiryaee2, Faezeh Akbari Moheb3.   

Abstract

Laryngospasm is an important complication of tonsillectomies. This study aimed to compare the effects of propofol versus lidocaine on prevention of laryngospasm in tonsillectomy. This randomized clinical trial included 102 patients who met the inclusion criteria. Patients were randomly divided into two groups treated with 0.5 mg/kg propofol (group P) or 1 mg/kg lidocaine 2% (group L). The frequencies of laryngospasm (within 10 min after extubation), agitation, nausea, vomiting, mean heart rate and mean arterial pressure (MAP) were assessed in both groups. Data were analyzed using SPSS software version 16 at a 95% confidence level. There were no significant differences between the two groups in terms of sex, age or weight. In the P group, the frequency of laryngospasm was significantly lower than L within10 minutes after extubation (4.1% versus 16.3%). Furthermore, the frequencies of agitation (p = 0.003), nausea and vomiting (p = 0.002) and mean heart rate (p = 0.026) were significantly higher in the L group than the P group. However, there were no differences between the two groups in terms of mean systolic and diastolic blood pressure, MAP, SPO2, awakening time, length of stay in recovery and frequency of shivering. Propofol can reduce the incidence of laryngospasm, agitation, nausea and vomiting but it has no effect on the patient's awakening time and length of stay in recovery.

Entities:  

Year:  2022        PMID: 35766592      PMCID: PMC9580534          DOI: 10.4081/ejtm.2022.10581

Source DB:  PubMed          Journal:  Eur J Transl Myol        ISSN: 2037-7452


  17 in total

1.  Gentle chest compression relieves extubation laryngospasm in children.

Authors:  Roshdi R Al-Metwalli; Hany A Mowafi; Salah A Ismail
Journal:  J Anesth       Date:  2010-10-26       Impact factor: 2.078

2.  Propofol for relief of extubation laryngospasm.

Authors:  M Nawfal; A Baraka
Journal:  Anaesthesia       Date:  2002-10       Impact factor: 6.955

Review 3.  [Laryngospasm].

Authors:  Adriano Bechara de Souza Hobaika; Michele Nacur Lorentz
Journal:  Rev Bras Anestesiol       Date:  2009 Jul-Aug       Impact factor: 0.964

4.  Risk factors for perioperative adverse respiratory events in children with upper respiratory tract infections.

Authors:  A R Tait; S Malviya; T Voepel-Lewis; H M Munro; M Seiwert; U A Pandit
Journal:  Anesthesiology       Date:  2001-08       Impact factor: 7.892

5.  Tonsil surgery efficiently relieves symptoms: analysis of 54 696 patients in the National Tonsil Surgery Register in Sweden.

Authors:  Joacim Stalfors; Elisabeth Ericsson; Claes Hemlin; Elisabeth Hultcrantz; Ingemar Månsson; Kristian Roos; Anne-Charlotte Hessén Söderman
Journal:  Acta Otolaryngol       Date:  2012-01-11       Impact factor: 1.494

6.  Negative pressure pulmonary oedema: a rare complication following general anaesthesia.

Authors:  Zeeshan Waheed; Javaid Ahmed Khan
Journal:  J Pak Med Assoc       Date:  2011-03       Impact factor: 0.781

Review 7.  The efficacy of lidocaine to prevent laryngospasm in children: a systematic review and meta-analysis.

Authors:  T Mihara; K Uchimoto; S Morita; T Goto
Journal:  Anaesthesia       Date:  2014-07-03       Impact factor: 6.955

8.  Incidence and risk factors of perioperative respiratory adverse events in children undergoing elective surgery.

Authors:  Chantal Mamie; Walid Habre; Cécile Delhumeau; Constance Barazzone Argiroffo; Alfredo Morabia
Journal:  Paediatr Anaesth       Date:  2004-03       Impact factor: 2.556

9.  The prevention of postoperative stridor and laryngospasm with topical lidocaine.

Authors:  J G Staffel; M C Weissler; E P Tyler; A F Drake
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1991-10

Review 10.  [Laryngospasm associated with anesthesia: diagnosis and management].

Authors:  Kazunori Koga; Takeyoshi Sata
Journal:  J UOEH       Date:  2004-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.